Thermo Fisher Replaces Remaining Buyback Capacity With $5 Billion Authorization

Thermo Fisher Scientific announced Nov. 5 that its board approved an authorization for up to $5 billion in stock repurchases, replacing a prior program with $1 billion of capacity still unused. The earlier program also had a $5 billion limit and was approved Nov. 6, 2025. Thermo Fisher had $1 billion remaining under it as of Sept. 26, so the new authorization does not add another $5 billion on top of that balance. The new authorization has no expiration date. Thermo Fisher can acquire shares on the open market or through negotiated transactions.

Source: TokenPost